2016
Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis
Rich JD, Beckwith CG, Macmadu A, Marshall BDL, Brinkley-Rubinstein L, Amon JJ, Milloy MJ, King MRF, Sanchez J, Atwoli L, Altice FL. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. The Lancet 2016, 388: 1103-1114. PMID: 27427452, PMCID: PMC5504684, DOI: 10.1016/s0140-6736(16)30379-8.Peer-Reviewed Original ResearchMeSH KeywordsAntiviral AgentsHepatitis BHepatitis CHepatitis, Viral, HumanHIV InfectionsHumansMass ScreeningPrisonersTuberculosisConceptsClinical careCommunity-based health careJail settingsHealth careDelivery of careCommunity-based treatmentProvision of treatmentHIV/AIDSPrison health careHepatitis BViral hepatitisMiddle-income countriesC virusClinical managementHigh-income countriesGeneral populationMedical careMental illnessInfectious diseasesOptimal deliverySubstance useCareTransmissible diseasesHIVTuberculosisGlobal burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
Dolan K, Wirtz AL, Moazen B, Ndeffo-mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, Hellard M, Beyrer C, Altice FL. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. The Lancet 2016, 388: 1089-1102. PMID: 27427453, DOI: 10.1016/s0140-6736(16)30466-4.Peer-Reviewed Original ResearchConceptsHepatitis B virusHepatitis C virusViral hepatitisChronic hepatitis B virusBurden of HIVOpioid agonist therapyPrevalence of HIVTreatment of HIVIncarceration of peopleComprehensive literature searchAgonist therapyActive tuberculosisHIV transmissionC virusB virusGlobal burdenPrevention interventionsGeneral populationGlobal epidemiologyHIVDrug useTuberculosisLiterature searchLarge-scale outbreaksHepatitisPublic health and international drug policy
Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, Cepeda J, Comfort M, Goosby E, Goulão J, Hart C, Kerr T, Lajous AM, Lewis S, Martin N, Mejía D, Camacho A, Mathieson D, Obot I, Ogunrombi A, Sherman S, Stone J, Vallath N, Vickerman P, Zábranský T, Beyrer C. Public health and international drug policy. The Lancet 2016, 387: 1427-1480. PMID: 27021149, PMCID: PMC5042332, DOI: 10.1016/s0140-6736(16)00619-x.Peer-Reviewed Original Research
2013
Burden of Infectious Diseases, Substance Use Disorders, and Mental Illness among Ukrainian Prisoners Transitioning to the Community
Azbel L, Wickersham JA, Grishaev Y, Dvoryak S, Altice FL. Burden of Infectious Diseases, Substance Use Disorders, and Mental Illness among Ukrainian Prisoners Transitioning to the Community. PLOS ONE 2013, 8: e59643. PMID: 23527238, PMCID: PMC3602355, DOI: 10.1371/journal.pone.0059643.Peer-Reviewed Original ResearchConceptsSubstance use disordersUse disordersInfectious diseasesHealth SurveyTreatment needsPrevalence of HIVContinuity of careAlcohol use disorderEpidemic of incarcerationHealth assessment surveyMultiple substance useViral hepatitisHIV incidenceHIV statusHIV prevalenceDrug injectionHIV epidemicHIV preventionSerological testingHealth StudyMental illnessHIVSubstance usePrevalenceDisease
2010
Testing for HIV, Sexually Transmitted Infections, and Viral Hepatitis in Jails: Still a Missed Opportunity for Public Health and HIV Prevention
Flanigan TP, Zaller N, Beckwith CG, Bazerman LB, Rana A, Gardner A, Wohl DA, Altice FL. Testing for HIV, Sexually Transmitted Infections, and Viral Hepatitis in Jails: Still a Missed Opportunity for Public Health and HIV Prevention. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2010, 55: s78-s83. PMID: 21406992, DOI: 10.1097/qai.0b013e3181fbc94f.Peer-Reviewed Original ResearchConceptsPublic health opportunityHIV preventionInfectious diseasesViral hepatitisHIV testingJail-based screeningHealth opportunitiesHigh-risk communitiesSTI diagnosisHIV infectionSTI testingCommunity prevalenceHigh riskHIVCommunity careInfectionPreventionDiseaseHepatitisTreatmentPublic healthIncarcerated individualsVast majorityPersons of colorTestingTreatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet 2010, 376: 367-387. PMID: 20650518, PMCID: PMC4855280, DOI: 10.1016/s0140-6736(10)60829-x.Peer-Reviewed Original ResearchMeSH KeywordsAIDS-Related Opportunistic InfectionsAnti-HIV AgentsAntipsychotic AgentsAntitubercular AgentsAntiviral AgentsBacterial InfectionsComorbidityCriminal LawDrug InteractionsDrug Resistance, BacterialEvidence-Based MedicineHepatitis, Viral, HumanHIV InfectionsHumansMedication AdherenceMental DisordersNarcoticsPrisonersSubstance-Related DisordersTuberculosisConceptsSubstance use disordersDrug usersAntiretroviral therapyViral hepatitisHIV treatmentHealth of HIVPharmacokinetic drug interactionsSubstance use comorbiditiesMedication-assisted therapyEvidence-based treatmentsDrug-resistant strainsHealth-related outcomesHealth service deliveryInfectious complicationsMultiple comorbiditiesHIV infectionPsychiatric comorbidityPoor adherenceClinical managementCardiovascular diseaseInadequate prescriptionCongregate settingsDrug interactionsComorbiditiesHIV
2007
Clinical Care of the HIV-Infected Drug User
Bruce RD, Altice FL. Clinical Care of the HIV-Infected Drug User. Infectious Disease Clinics Of North America 2007, 21: 149-179. PMID: 17502234, PMCID: PMC2128697, DOI: 10.1016/j.idc.2007.03.009.Peer-Reviewed Original Research
1998
Predictors of HIV Infection Among Newly Sentenced Male Prisoners
Altice F, Mostashari F, Selwyn P, Checko P, Singh R, Tanguay S, Blanchette E. Predictors of HIV Infection Among Newly Sentenced Male Prisoners. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: 444-453. PMID: 9715840, DOI: 10.1097/00042560-199808150-00005.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsBlood TransfusionConfounding Factors, EpidemiologicConnecticutEmergency Medical ServicesForecastingHematologic DiseasesHepatitis, Viral, HumanHIV AntibodiesHIV SeropositivityHIV-1HumansMaleMental DisordersPrevalencePrimary Health CarePrisonersRisk FactorsSexual BehaviorSexually Transmitted DiseasesSubstance Abuse, IntravenousTuberculosisWounds, GunshotConceptsHIV infectionAppropriate risk-reduction interventionsPotent combination antiretroviral therapyElevated aspartate aminotransferase levelsSelf-reported high-risk behaviorsHIV testing resourcesCombination antiretroviral therapyHIV-seropositive personsInjection drug useAspartate aminotransferase levelsAge-adjusted ratesRisk reduction interventionsMultivariate regression analysisHigh-risk behaviorsPrevalence of individualsComprehensive HIVAntiretroviral therapyHIV careAminotransferase levelsHIV serosurveyIndependent predictorsLaboratory markersHIV statusHIV prevalenceBlack race